Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, S.
Right arrow Articles by Law, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, S.
Right arrow Articles by Law, P.
Stem Cells, Vol. 17, No. 5, 265-272, September 1999
© 1999 AlphaMed Press

Correlation Between IL-3 Receptor Expression and Growth Potential of Human CD34+ Hematopoietic Cells from Different Tissues

Shiang Huanga, Zhang Chenb, Ji Feng Yub, Dennis Younga, Asad Basheya, Anthony D. Hoc, Ping Lawa

a University of California San Diego, Division of Blood & Marrow Transplantation, La Jolla, California, USA;
b PharMingen Corporation, San Diego, California, USA;
c University of Heidelberg, Department of Internal Medicine V, Heidelberg, Germany

Key Words. CD34+ cells • CD123 • IL-3 receptor • Hematopoietic cells • Committed progenitors • Erythroid progenitors

Dr. Ping Law, Division of Blood and Marrow Transplantation, University of California San Diego, 9300 Campus Point Drive Mailcode 7621, La Jolla, California 92037-7621, USA.

CD123 ({alpha}-subunit of IL-3 receptor) expression on primitive and committed human hematopoietic cells was studied by multicolor sorting and single-cell culture. The sources of cells included fetal liver (FLV), fetal bone marrow, umbilical cord blood, adult bone marrow and mobilized peripheral blood. Three subsets of CD34+ cells were defined by the levels of surface CD123: CD123negative, CD123low, and CD123bright. Coexpression of lineage markers showed that a majority of CD34+CD123bright cells were myeloid and B-lymphoid progenitors, while erythroid progenitors were mainly in the CD34+CD123negative subset. The CD34+CD123low subset contained a heterogeneous distribution of early and committed progenitor cells. Single CD34+ cells from the CD123 subsets were cultured in a cytokine cocktail of stem cell factor, interleukin 3 (IL-3), IL-6, GM-CSF, erythropoietin, insulin-like growth factor-1, and basic fibroblast growth factor. After 14 days of incubation, a higher cloning efficiency (CE) was observed in the CD34+CD123negative and CD34+CD123low fractions (37 ± 23% and 44 ± 23%, respectively) than in the CD34+CD123bright fraction (15 ± 21%). Using previously published criteria that colonies containing dispersed, translucent cells (dispersed growth pattern, DGP) were derived from primitive cells and that colonies composed solely of clusters were from committed cells, early precursors were distributed evenly in the CD34+CD123negative and CD34+CD123low subsets. When CD38 and CD90 (Thy-1) were used for further characterization of CD34+ cells from FLV, CE increased from 37 ± 23% in CD123negative to 70 ± 19% in CD123negativeCD38- and from 44 ± 23% in CD123low to 66 ± 19% in CD123lowCD38-. No significant increase in CE or DGP progenitors was observed when CD34+ cells were sorted by CD90 and CD123. We concluded that: A) high levels of CD123 were expressed on B-lymphoid and myeloid progenitors; B) early erythroid progenitors had little or no surface CD123, and C) primitive hematopoietic cells are characterized by CD123negative/low expression.




This article has been cited by other articles:


Home page
BloodHome page
D. Baksh, J. E. Davies, and P. W. Zandstra
Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment
Blood, November 1, 2005; 106(9): 3012 - 3019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Lehtonen, E. Lehtonen, K. Kudlicka, H. Holthofer, and M. G. Farquhar
Nephrin Forms a Complex with Adherens Junction Proteins and CASK in Podocytes and in Madin-Darby Canine Kidney Cells Expressing Nephrin
Am. J. Pathol., September 1, 2004; 165(3): 923 - 936.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. G. Manz, T. Miyamoto, K. Akashi, and I. L. Weissman
Prospective isolation of human clonogenic common myeloid progenitors
PNAS, September 3, 2002; 99(18): 11872 - 11877.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. J. Weston, C. M. McConville, J. R. Mann, P. J. Darbyshire, S. Lawson, J. Gordon, P. A. H. Moss, A. Malcolm, R. Taylor, and T. Stankovic
Molecular Analysis of Single Colonies Reveals a Diverse Origin of Initial Clonal Proliferation in B-Precursor Acute Lymphoblastic Leukemia that Can Precede the t(12;21) Translocation
Cancer Res., December 1, 2001; 61(23): 8547 - 8553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 1999 by AlphaMed Press.